Companies / Galectin Therapeutics Inc / Activity
Activity — Galectin Therapeutics Inc
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2025 as of | Barclays PLC 13F manager | New | Common Stock | $442.6K | +106K | 106,401 0.16% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common Stock | $412.6K | +148K | 147,900 0.22% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $219.9K | +47K | 47,403 0.07% of shares | low |
| Q1 2026 as of | &Partners 13F manager | New | Common Stock | $114.4K | +41K | 41,000 0.06% of shares | low |
| Q1 2026 as of | Pekin Hardy Strauss, Inc. 13F manager | New | Common Stock | $83.7K | +30K | 30,000 0.05% of shares | low |
| Q2 2024 as of | Barclays PLC 13F manager | New | Common Stock | $15.8K | +7K | 6,989 0.01% of shares | low |